Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

1.30
BATS BZX Real-Time Price
As of 1:17pm ET
 -0.10 / -7.14%
Today’s Change
1.20
Today|||52-Week Range
3.87
-51.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$16.0M

Company Description

Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

Contact Information

Genetic Technologies Ltd.
60-66 Hanover Street
Fitzroy Victoria (vic) 3065
P:(138) 412-7000
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Eutillio BuccilliCEO, Chief Operating Officer & Executive Director
Kevin FischerChief Financial Officer & Secretary
Richard AllmanScientific Director
Susan J. GrossSenior Medical Director
Diana NewportDirector-Quality & Business Operations